Imaginostics

Curated by Signal

Provider of solution for magnetic resonance imaging biomarkers for diagnosis of neurological disorder

Overview

Imaginostics provides the solution for magnetic resonance imaging (MRI) biomarkers for the diagnosis of neurological disorders like Alzheimer’s Disease and Dementias. It offers its proprietary software solution for non-invasive early diagnostics. The technology detects the biomarker of Cance, Cardiovascular, Kidney, and Alzheimer’s Disease and Related Dementias. The platform can be integrated with the existing MRI scanners and hardware of users for data visualization.

Key facts

Founded: 2011
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Double U
Platform offering workout tracker app
Health TechnologyMiami, United States
Catalytic DS
Cloud based software for R&D workflow management
Health TechnologyNew York City, United States
NiN Healthcare
Medical Device and Service Marketplace for healthcare professionals
Health TechnologyPalo Alto, United States

About Imaginostics

What does Imaginostics do?

Imaginostics provides the solution for magnetic resonance imaging (MRI) biomarkers for the diagnosis of neurological disorders like Alzheimer’s Disease and Dementias.

Where is Imaginostics headquartered?

Imaginostics is headquartered in Cambridge, United States.

When was Imaginostics founded?

Imaginostics was founded in 2011.

Which sector is Imaginostics in?

Imaginostics operates in Health Technology.

Who are Imaginostics's competitors?

Companies similar to Imaginostics include Double U, Catalytic DS, and NiN Healthcare.